Qube Research & Technologies (QRT)’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PLRX
LCM
Qube Research & Technologies (QRT)'s PLRX Position: Q3 2026 in Review
Qube Research & Technologies (QRT) sold out of Pliant Therapeutics (PLRX) in Q3 2026, closing a stake of 10,033 shares — an estimated $11.4K sold.
Qube Research & Technologies (QRT) first reported a position in PLRX in Q2 2022 and held it in 10 quarters. The position peaked at $4.68M in Q1 2023. 84 funds tracked by Wall St. Rank hold PLRX as of Q3 2026.
- Qube Research & Technologies (QRT) reported no remaining Pliant Therapeutics position as of Q3 2026 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 10,033 Pliant Therapeutics shares in Q3 2026, an estimated $11.4K.
- Qube Research & Technologies (QRT) first reported a position in Pliant Therapeutics in Q2 2022 and held it in 10 quarters.
- Qube Research & Technologies (QRT)'s Pliant Therapeutics position peaked at $4.68M in Q1 2023.
- 84 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.